Last week’s hot topic on Scleroderma was Pulmonary Hypertension Prevented, Treated by Macitentan in Systemic Sclerosis Mouse Model written by Magdalena Kegel.
This article is about a study which showed that macitentan (Opsumit) can prevent pulmonary arterial hypertension (PAH) in a mouse model of systemic sclerosis (SSc) by preventing heart tissue remodeling and functional changes. The results were presented this week by E. Derrett-Smith at the 4th Systemic Sclerosis World Congress in Lisbon, Portugal.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?